[
    [
        {
            "time": "",
            "original_text": "港股医药股一枝独秀！更有个股暴涨280%！惊呆了，目前港股估值比“非典”和金融危机时还低！",
            "features": {
                "keywords": [
                    "港股",
                    "医药股",
                    "暴涨",
                    "估值",
                    "非典",
                    "金融危机"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股医药股一枝独秀！更有个股暴涨280%！惊呆了，目前港股估值比“非典”和金融危机时还低！",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【中信建投医药|行业周报】疫情带来阶段性行情，长期投资逻辑不会变",
            "features": {
                "keywords": [
                    "中信建投",
                    "医药",
                    "疫情",
                    "阶段性行情",
                    "长期投资逻辑"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【中信建投医药|行业周报】疫情带来阶段性行情，长期投资逻辑不会变",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "中信建投证券：肺炎疫情难阻看好医药行业的结构性投资机会2.0版",
            "features": {
                "keywords": [
                    "中信建投证券",
                    "肺炎疫情",
                    "医药行业",
                    "结构性投资机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中信建投证券：肺炎疫情难阻看好医药行业的结构性投资机会2.0版",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]